Evidence map›Paper›PMID 32286302›Full record

ArticleNature communications2020

Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection.

Emily Adland, Jane Millar, Nomonde Bengu, Maximilian Muenchhoff, Rowena Fillis, Kenneth Sprenger, Vuyokasi Ntlantsana, Julia Roider, Vinicius Vieira, Katya Govender and 24 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Sex Differences in HIV Infection.Current topics in microbiology and immunology · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 16 institutions in 5 countries.

Emily Adland *Department of Paediatrics, University of Oxford, Oxford, UK.
Jane Millar *Department of Paediatrics, University of Oxford, Oxford, UK.
Nomonde BenguUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
Maximilian MuenchhoffMax von Pettenkofer Institute, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany.
Rowena FillisUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
Kenneth SprengerUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.ORCID http://orcid.org/0000-0002-5460-1675
Vuyokasi NtlantsanaDepartment of Medicine, University of KwaZulu-Natal, Durban, South Africa.ORCID http://orcid.org/0000-0002-5882-100X
Julia RoiderGerman Center for Infection Research (DZIF), Partner site Munich, Munich, Germany.
Vinicius VieiraDepartment of Paediatrics, University of Oxford, Oxford, UK.
Katya GovenderAfrica Health Research Institute, Durban, South Africa.
John AdamsonAfrica Health Research Institute, Durban, South Africa.
Nelisiwe NxeleHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Christina OchsenbauerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0003-1166-5879
John KappesDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Luisa MoriDepartment of Paediatrics, University of Oxford, Oxford, UK.
Jeroen van LobensteinStanger Hospital, KwaDukuza, KwaZulu-Natal, South Africa.
Yeney GrazaKwaZulu-Natal Department of Health, Pietermartizburg, South Africa.
Kogielambal ChinniahMahatma Gandhi Memorial Hospital, Phoenix, KwaZulu-Natal, South Africa.
Constant KapongoQueen Nandi Regional Hospital, Empangeni, KwaZulu-Natal, South Africa.
Roopesh BhoolaEdendale Hospital, Pietermartizburg, KwaZulu-Natal, South Africa.
Malini KrishnaEdendale Hospital, Pietermartizburg, KwaZulu-Natal, South Africa.
Philippa C MatthewsNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-4036-4269
Ruth Penya PoderosIrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Marta Colomer LluchIrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.ORCID http://orcid.org/0000-0001-5233-3606
Maria C PuertasIrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.ORCID http://orcid.org/0000-0002-6750-2318
Julia G PradoIrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.ORCID http://orcid.org/0000-0002-5439-4645
Neil McKerrowKwaZulu-Natal Department of Health, Pietermartizburg, South Africa.
Moherndran ArcharyDepartment of Paediatrics, University of KwaZulu-Natal, Durban, South Africa.
Thumbi Ndung'uHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Andreas GrollTU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.
Pieter JoosteDepartment of Paediatrics, Kimberley Hospital, Northern Cape, South Africa.ORCID http://orcid.org/0000-0002-8635-2255
Javier Martinez-PicadoIrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.ORCID http://orcid.org/0000-0002-4916-2129
Marcus AltfeldVirus Immunology Unit, Heinrich-Pette-Institut, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5972-2997
Philip GoulderDepartment of Paediatrics, University of Oxford, Oxford, UK. philip.goulder@paediatrics.ox.ac.uk.
University of Oxford · GBIrsiCaixa · ESUmkhuseli Innovation and Research Management · ZAUniversity of KwaZulu-Natal · ZAAfrica Health Research Institute · ZAEdendale Hospital · ZAGerman Center for Infection Research · DERagon Institute of MGH, MIT and Harvard · USUniversity of Alabama at Birmingham · USKimberley Hospital · ZALeibniz Institute of Virology (LIV) · DEMahatma Gandhi Memorial Hospital · ZAQueen Nandi Regional Hospital · ZAStanger Hospital · ZATU Dortmund University · DEUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

Maximising Cure Potential in Paediatric HIV InfectionR01AI133673 · NIAID · UNIVERSITY OF OXFORD · PI GOULDER, PHILIP J · 2017 to 2021
$1.4M
NIAID NIH HHS R01 AI133673Wellcome TrustWellcome Trust WT 104748MAWellcome Trust WT 110110
6 · The paper itself

Abstract

Female children and adults typically generate more efficacious immune responses to vaccines and infections than age-matched males, but also suffer greater immunopathology and autoimmune disease. We here describe, in a cohort of > 170 in utero HIV-infected infants from KwaZulu-Natal, South Africa, fetal immune sex differences resulting in a 1.5-2-fold increased female susceptibility to intrauterine HIV infection. Viruses transmitted to females have lower replicative capacity (p = 0.0005) and are more type I interferon-resistant (p = 0.007) than those transmitted to males. Cord blood cells from females of HIV-uninfected sex-discordant twins are more activated (p = 0.01) and more susceptible to HIV infection in vitro (p = 0.03). Sex differences in outcome include superior maintenance of aviraemia among males (p = 0.007) that is not explained by differential antiretroviral therapy adherence. These data demonstrate sex-specific innate immune selection of HIV associated with increased female susceptibility to in utero infection and enhanced functional cure potential among infected males.

Indexed as

Anti-Retroviral AgentsCohort StudiesFemaleHIV-1HIV InfectionsHumansImmunity, InnateInfectious Disease Transmission, VerticalInterferonsKaplan-Meier EstimateMalePhylogenySex FactorsTranslational Research, BiomedicalAnti-Retroviral AgentsInterferons

Identifiers

PMID32286302
PMCPMC7156749
OpenAlexW3015954539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.